Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Clearway Energy Class C
CWEN
$7B
| $24.8M | ﹤0.01% |
819,761
+34,446
| +4% | +$1.03M |
|
1802
PAR Technology
PAR
$776M
| $24.7M | ﹤0.01% |
402,034
+7,695
| +2% | +$494K |
|
1803
SelectQuote
SLQT
$129M
| $24.7M | ﹤0.01% |
1,912,603
+508,889
| +36% | +$7.66M |
|
|
CSII
1804
DELISTED
Cardiovascular Systems, Inc.
CSII
| $24.7M | ﹤0.01% |
751,103
-20,757
| -3% | -$774K |
|
1805
Oxford Industries
OXM
$548M
| $24.6M | ﹤0.01% |
272,816
-2,378
| -0.9% | -$216K |
|
|
ARCH
1806
DELISTED
Arch Resources, Inc.
ARCH
| $24.6M | ﹤0.01% |
265,185
+16,969
| +7% | +$1.19M |
|
1807
Oceaneering
OII
$5.12B
| $24.6M | ﹤0.01% |
1,846,454
+107,988
| +6% | +$1.41M |
|
|
RWT
1808
Redwood Trust
RWT
$597M
| $24.6M | ﹤0.01% |
1,906,958
+266
| +0% | +$3.25K |
|
1809
Lightspeed Commerce
LSPD
$1.41B
| $24.6M | ﹤0.01% |
256,564
+51,980
| +25% | +$5.16M |
|
1810
Vipshop
VIPS
$6.77B
| $24.5M | ﹤0.01% |
2,217,032
+310,207
| +16% | +$4.88M |
|
1811
TriMas Corp
TRS
$1.39B
| $24.5M | ﹤0.01% |
757,045
+6,453
| +0.9% | +$199K |
|
|
KRA
1812
DELISTED
Kraton Corporation
KRA
| $24.5M | ﹤0.01% |
536,567
+4,183
| +0.8% | +$166K |
|
|
SUMO
1813
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $24.5M | ﹤0.01% |
1,517,351
+681,222
| +81% | +$13.5M |
|
|
MORF
1814
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $24.3M | ﹤0.01% |
429,717
+116,888
| +37% | +$7.07M |
|
1815
Columbus McKinnon
CMCO
$554M
| $24.3M | ﹤0.01% |
502,992
-2,884
| -0.6% | -$131K |
|
1816
FB Financial Corp
FBK
$3.1B
| $24.3M | ﹤0.01% |
566,938
+8,483
| +2% | +$336K |
|
1817
Castle Biosciences
CSTL
$950M
| $24.3M | ﹤0.01% |
365,368
+25,293
| +7% | +$1.78M |
|
1818
James River Group Holdings
JRVR
$201M
| $24.2M | ﹤0.01% |
642,076
+18,221
| +3% | +$665K |
|
1819
AZZ Inc
AZZ
$4.52B
| $24.2M | ﹤0.01% |
454,459
+9,694
| +2% | +$510K |
|
|
ONT
1820
Onterris Inc
ONT
$606M
| $24.1M | ﹤0.01% |
390,546
+94,534
| +32% | +$4.94M |
|
1821
Ocugen
OCGN
$458M
| $24.1M | ﹤0.01% |
3,356,816
+173,982
| +5% | +$1.28M |
|
1822
Materion
MTRN
$5.95B
| $24M | ﹤0.01% |
350,315
-990
| -0.3% | -$70.8K |
|
1823
Deluxe
DLX
$1.12B
| $24M | ﹤0.01% |
669,007
-26,093
| -4% | -$1.06M |
|
|
DRNA
1824
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $24M | ﹤0.01% |
1,190,676
+2,981
| +0.3% | +$82.3K |
|
1825
US Physical Therapy
USPH
$1.23B
| $24M | ﹤0.01% |
216,844
+1,647
| +0.8% | +$188K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.